Previous studies have demonstrated that AKR1B1 inhibition by sorbinil and zopolrestat hinders EGF/FGF-induced growth, migration and invasion through GS-DHN oxidative stress mediator-induced NF-κB activation on HT29 and KM20 colon cancer cells [41]. Here, EGF is linked to colonic neoplasm.